Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

11,349

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

Inactivated COVID-19 Vaccine

The inactivated COVID-19 vaccine was manufactured by Sinovac Research\& Development Co., Ltd..600SU Inactivated SARS-COV-2 virus in 0·5 mL of aluminium hydroxide solution per injection

BIOLOGICAL

Controlled vaccine

The placebo was manufactured by Sinovac Research\& Development Co., Ltd.The composition is aluminium hydroxide,The appearance of the placebo is consistent with the vaccine, which is a milky-white suspension.

Trial Locations (38)

1459

Soweto Clinical Trials Center, Soweto

1501

Worthwhile Clinical Trials, Benoni

1818

Mecru Clinical Research Unit, Ga-Rankuwa

2113

Newtown Clinical Research Centre, Johannesburg

2196

Sandton Medical Research Centre, Sandton

7530

Tiervlei Trial Centre, Bellville

7626

Be Part Research, Paarl

13700

Hospital Seberang Jaya, Seberang Jaya

30450

Hospital Raja Permaisuri Bainun, Ipoh

42000

Klinik Kesihatan Pandamaran, Port Klang

42300

Hospital Pengajar UiTM Puncak Alam, Bandar

47000

Hospital Sungai Buloh, Sungai Buloh

56100

Klinik Kesihatan Cheras Baru, Cheras

59100

University Malaya Medical Centre, Kuala Lumpur

88996

Hospital Wanita dan Kanak-Kanak Sabah, Kota

96000

Hospital Sibu, Sibu

980000

Hospital Miri, Miri

Unknown

Hospital de Puerto Montt, Port Montt

Clínica Alemana Valdivia, Valdivia

Hospital Gustavo Fricke, Viña del Mar

Hospital Universidad Clinico de Antofagasta, Antofagasta

Hospital Roberto del Río, Independencia

Clínica San Carlos de Apoquindo, Las Condes

Clínica Universidad de los Andes, Las Condes

San Joaquín, Macul

Hospital Sótero del Río, Puente Alto

Hospital Ezequial Gonzalez, San Miguel

Marcoleta, Santiago

Clínica Alemana, Vitacura

Asian Hospital and Medical Center, City of Muntinlupa

National Children's Hospital, Manila

Philippine Children's Medical Center, Manila

Philippine General Hospital, Manila

University of Philippines, National Institute of Health, Manila

Reimed Reicherpark, Boksburg

0204

Mecru Clinical Research Unit, Bellville

0250

Madibeng Centre for Research, Madibeng

0083

Global Clinical Trials, Pretoria

All Listed Sponsors
lead

Sinovac Research and Development Co., Ltd.

INDUSTRY

NCT04992260 - Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents | Biotech Hunter | Biotech Hunter